Kathleen A. Leppig

8.6k citations

57 papers · 2.0k indexed · 1 hit paper · h-index 23

Genetics top 5%
Molecular Biology
Cellular and Molecular Neuroscience top 5%
Neurology top 5%
Neurology top 5%

Co-authors: Christine M. Distèche M. William Lensch Phillip D. Swanson Shannon J. Odelberg Thomas D. Bird Brooke Smith Phillip F. Chance Norisada Matsunami
Topics: BRCA gene mutations in cancer (16 papers)Genomics and Rare Diseases (13 papers)Genomic variations and chromosomal abnormalities (9 papers)
Cited by: Cellular and Molecular Neuroscience Neurology Genetics
Journals: Cell Proceedings of the National Academy of Sciences Blood
Partner nations: United States Canada France

In The Last Decade

Kathleen A. Leppig

55 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA deletion associated with hereditary neuropathy with liability to pressure palsies

1993 606 citations Kathleen A. Leppig et al. profile →

Peers

Countries citing papers authored by Kathleen A. Leppig

Since Specialization

Citations

This map shows the geographic impact of Kathleen A. Leppig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen A. Leppig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen A. Leppig more than expected).

Fields of papers citing papers by Kathleen A. Leppig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen A. Leppig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen A. Leppig. The network helps show where Kathleen A. Leppig may publish in the future.

Co-authorship network of co-authors of Kathleen A. Leppig

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen A. Leppig. A scholar is included among the top collaborators of Kathleen A. Leppig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen A. Leppig. Kathleen A. Leppig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	“I Didn't Have to Worry about It”: Patient and Family Experiences with Health System Involvement in Notifying Relatives of Genetic Test Results 2024 ·Public Health Genomics ·Paula R. Blasi,Jamilyn M. Zepp,Aaron Scrol,John Ewing,Melissa Anderson,James D. Ralston,Stephanie M. Fullerton,Kathleen A. Leppig,Nora B. Henrikson	2
2	Genetic predictors of blood pressure traits are associated with preeclampsia 2024 ·Scientific Reports ·(unknown),Jacklyn N. Hellwege,(unknown),(unknown),Gail P. Jarvik,Ian B. Stanaway,Kathleen A. Leppig,Geetha Chittoor,M. Geoffrey Hayes,Ozan Dikilitas,Iftikhar Kullo,Ingrid A. Holm,Shefali S. Verma,Todd L. Edwards,Digna R. Velez Edwards	1
3	Implementation matters: How patient experiences differ when genetic counseling accompanies the return of genetic variants of uncertain significance 2022 ·PubMed Central ·(unknown),Nora B. Henrikson,James D. Ralston,Kathleen A. Leppig,Aaron Scrol,Gail P. Jarvik,(unknown),Eric B. Larson,Andrea L. Hartzler	0
4	Impact of returning unsolicited genomic results to nongenetic health care providers in the eMERGE III Network 2022 ·Genetics in Medicine ·Jill A. Madden,(unknown),Janet L. Williams,Melanie F. Myers,Kathleen A. Leppig,Ellen Wright Clayton,Georgia L. Wiesner,Ingrid A. Holm	3
5	Patient and Family Preferences on Health System-Led Direct Contact for Cascade Screening 2021 ·Journal of Personalized Medicine ·Nora B. Henrikson,Paula R. Blasi,Marlaine Figueroa Gray,(unknown),Aaron Scrol,James D. Ralston,Stephanie M. Fullerton,Catherine Lim,(unknown),Kathleen A. Leppig	25
6	Effect of a Randomized Trial of a Web-Based Intervention on Patient–Provider Communication About Breast Density 2021 ·Journal of Women s Health ·Erin J. Aiello Bowles,Suzanne C. O’Neill,Tengfei Li,Sarah Knerr,Jeanne S. Mandelblatt,Marc D. Schwartz,Jinani Jayasekera,Kathleen A. Leppig,Kelly Ehrlich,David Farrell,Hongyuan Gao,Amanda L. Graham,George Luta,Karen J. Wernli	2
7	Using Protection Motivation Theory to Predict Intentions for Breast Cancer Risk Management: Intervention Mechanisms from a Randomized Controlled Trial 2021 ·Journal of Cancer Education ·Claire C. Conley,Karen J. Wernli,Sarah Knerr,Tengfei Li,Kathleen A. Leppig,Kelly Ehrlich,David Farrell,Hongyuan Gao,Erin J. Aiello Bowles,Amanda L. Graham,George Luta,Jinani Jayasekera,Jeanne S. Mandelblatt,Marc D. Schwartz,Suzanne C. O’Neill	2
8	Reanalysis of eMERGE phase III sequence variants in 10,500 participants and infrastructure to support the automated return of knowledge updates 2021 ·Genetics in Medicine ·Hana Zouk,Wanfeng Yu,Andrea M. Oza,Megan Hawley,(unknown),Christopher Koch,Lisa Mahanta,John B. Harley,Gail P. Jarvik,Elizabeth W. Karlson,Kathleen A. Leppig,Melanie F. Myers,Cynthia A. Prows,Marc S. Williams,Scott T. Weiss,Matthew S. Lebo,Heidi L. Rehm	7
9	Participant choices for return of genomic results in the eMERGE Network 2020 ·Genetics in Medicine ·Christin Hoell,Julia Wynn,Luke V. Rasmussen,Keith Marsolo,Sharon Aufox,Wendy K. Chung,John J. Connolly,Robert R. Freimuth,(unknown),Håkon Håkonarson,Margaret Harr,Ingrid A. Holm,Iftikhar J. Kullo,Philip E. Lammers,Kathleen A. Leppig,Nancy D. Leslie,Melanie F. Myers,Richard R. Sharp,Maureen E. Smith,Cynthia A. Prows	24
10	“It would be so much easier”: health system-led genetic risk notification—feasibility and acceptability of cascade screening in an integrated system 2019 ·Journal of Community Genetics ·Nora B. Henrikson,Paula R. Blasi,Stephanie M. Fullerton,Jane Grafton,Kathleen A. Leppig,Gail P. Jarvik,Eric B. Larson	12
11	A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir–Torre variant of Lynch syndrome 2014 ·Genetics in Medicine ·Maegan E. Roberts,Douglas L. Riegert‐Johnson,Brittany C. Thomas,Kandelaria M. Rumilla,Colleen S. Thomas,Michael G. Heckman,(unknown),Nancy Hanson,Kathleen A. Leppig,Justin Lim,Mark A. Cappel	81
12	Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network 2012 ·Genetics in Medicine ·Stephanie M. Fullerton,Wendy A. Wolf,Kyle B. Brothers,Ellen Wright Clayton,Dana C. Crawford,Joshua C. Denny,Philip Greenland,Barbara A. Koenig,Kathleen A. Leppig,Noralane M. Lindor,Catherine A. McCarty,Amy L. McGuire,Eugenia McPeek Hinz,Daniel B. Mirel,Erin M. Ramos,Marylyn D. Ritchie,Maureen E. Smith,Carol Waudby,Wylie Burke,Gail P. Jarvik	77
13	Fanconi anemia‐like presentation in an infant with constitutional deletion of 21q including the RUNX1 gene 2011 ·American Journal of Medical Genetics Part A ·Eleanor S. Click,Barbara Cox,Susan B. Olson,Markus Grompe,Yassmine Akkari,Lisa A. Moreau,Akiko Shimamura,(unknown),Yajuan J. Liu,Kathleen A. Leppig,Dana C. Matthews,Melissa A. Parisi	15
14	Motivating Factors for Physician Ordering of Factor V Leiden Genetic Tests 2009 ·Archives of Internal Medicine ·Lucia A. Hindorff,Wylie Burke,(unknown),Kenneth Rice,Thomas Lumley,Kathleen A. Leppig,Frits R. Rosendaal,Eric B. Larson,Bruce M. Psaty	16
15	Genotype–phenotype analysis of TCF4 mutations causing Pitt-Hopkins syndrome shows increased seizure activity with missense mutations 2009 ·Genetics in Medicine ·Jill A. Rosenfeld,Kathleen A. Leppig,Blake C. Ballif,Heidi Thiese,Christine Erdie-Lalena,(unknown),(unknown),J. Edward Spence,Anne M. Bandholz,Urvashi Surti,Jonathan Zonana,Kory Keller,Wendy S. Meschino,Bassem A. Bejjani,Beth S. Torchia,Lisa G. Shaffer	55
16	Clinical and molecular features of congenital disorder of glycosylation in patients with type 1 sialotransferrin pattern and diverse ethnic origins 2002 ·The Journal of Pediatrics ·Gregory M. Enns,Robert D. Steiner,Neil R.M. Buist,Charles A. Cowan,Kathleen A. Leppig,Marjorie F. McCracken,Vibeke Westphal,Hudson H. Freeze,John F. O’Brien,Jaak Jaeken,Gert Matthijs,(unknown),Louanne Hudgins	31
17	Familial cryptic (20;21) translocation identified by in situ hybridization technologies 2000 ·American Journal of Medical Genetics ·Kathleen A. Leppig,Susie Ball,(unknown),Kent E. Opheim,Thomas H. Norwood	5
18	Familial neurofibromatosis 1 microdeletions: Cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata 1997 ·American Journal of Medical Genetics ·Kathleen A. Leppig,Paige Kaplan,David Viskochil,Molly Weaver,June Ortenberg,Karen Stephens	84
19	Smooth muscle tumors associated with X-linked Alport syndrome: Carrier detection in females 1995 ·Kidney International ·Karin Dahan,Laurence Heidet,Jing Zhou,Gabrielle Mettler,Kathleen A. Leppig,Willem Proesmans,Albert David,Bernard Roussel,J. G. Mongeau,(unknown),Jean‐Pierre Grünfeld,Marie-Claire Gübler,Corinne Antignac	29
20	Predictive value of minor anomalies: II. Use in cohort studies to identify teratogens 1987 ·Teratology ·Lewis B. Holmes,(unknown),Kathleen A. Leppig,Cristina I. Cann,(unknown),B. Frank Polk	42

About Kathleen A. Leppig

Kathleen A. Leppig is a scholar working on Genetics, Cancer Research and Genetics, having authored 57 papers that have together received 2.0k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (16 papers), Genomics and Rare Diseases (13 papers) and Genomic variations and chromosomal abnormalities (9 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (507 citations), Neurology (219 citations) and Genetics (681 citations). Kathleen A. Leppig has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Christine M. Distèche, M. William Lensch, Phillip D. Swanson, Shannon J. Odelberg, Thomas D. Bird, Brooke Smith, Phillip F. Chance, Norisada Matsunami, Cristina I. Cann and Lewis B. Holmes. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact